Union Korea Pharm Balance Sheet Health
Financial Health criteria checks 3/6
Union Korea Pharm has a total shareholder equity of ₩23.5B and total debt of ₩38.4B, which brings its debt-to-equity ratio to 163.4%. Its total assets and total liabilities are ₩92.3B and ₩68.8B respectively.
Key information
163.4%
Debt to equity ratio
₩38.42b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩7.58b |
| Equity | ₩23.51b |
| Total liabilities | ₩68.81b |
| Total assets | ₩92.32b |
Recent financial health updates
Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23
Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27
Recent updates
Union Korea Pharm Co., Ltd.'s (KOSDAQ:080720) 26% Share Price Plunge Could Signal Some Risk
Jul 22Is Union Korea Pharm (KOSDAQ:080720) A Risky Investment?
Apr 23Union Korea Pharm (KOSDAQ:080720) Is Carrying A Fair Bit Of Debt
Jan 27What Percentage Of Union Korea Pharm Co., Ltd. (KOSDAQ:080720) Shares Do Insiders Own?
Dec 22The Union Korea Pharm (KOSDAQ:080720) Share Price Has Gained 38% And Shareholders Are Hoping For More
Nov 17Financial Position Analysis
Short Term Liabilities: A080720's short term assets (₩48.7B) do not cover its short term liabilities (₩63.1B).
Long Term Liabilities: A080720's short term assets (₩48.7B) exceed its long term liabilities (₩5.7B).
Debt to Equity History and Analysis
Debt Level: A080720's net debt to equity ratio (131.2%) is considered high.
Reducing Debt: A080720's debt to equity ratio has increased from 38.1% to 163.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable A080720 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: A080720 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 28.5% per year.